Assyro AI
Consulting Use Cases
ConsultingPV/Drug Safety

PV/Drug Safety Solutions for Consulting

Assyro AI empowers pharmacovigilance professionals in regulatory consulting firms with intelligent regulatory tools. Assyro AI supports pharmacovigilance professionals with regulatory intelligence on safety reporting requirements, signal detection, and risk management. Stay compliant with global PV obligations and evolving safety standards.

What PV/Drug Safety Teams Do

  • Managing adverse event reporting and safety databases
  • Preparing periodic safety reports (PSUR/PBRER)
  • Conducting signal detection and safety surveillance
  • Developing and maintaining risk management plans
  • Ensuring compliance with global PV regulations

Challenges in Consulting

  • Managing increasing volume of safety data and reports
  • Tracking country-specific reporting requirements and timelines
  • Keeping up with evolving pharmacovigilance regulations
  • Revenue is capped because you can only manage 3-5 client programs manually
  • 80% of billable time goes to document formatting instead of strategic advisory

How Assyro AI Helps

  • Track global pharmacovigilance regulations and requirements
  • Monitor FDA and EMA safety-related announcements
  • Generate safety documentation with AI assistance
  • Manage 15+ client programs from one dashboard with per-client workspaces and tracking
  • Shift billable mix from 80% document work to 80% strategic advisory with AI-assisted drafting

Key Skills We Support

Adverse event assessmentSignal detectionSafety reportingRisk managementRegulatory compliance

Regulations We Cover

Global regulatory frameworksFDA/EMA/PMDA guidanceICH guidelinesIndustry best practices

Frequently Asked Questions

Assyro AI provides PV teams with regulatory intelligence on global safety reporting requirements, signal detection guidance, and risk management frameworks. Our AI helps track changing PV regulations across markets.

Assyro AI assists with PSUR/PBRER preparation by tracking regulatory templates, timeline requirements, and content expectations. Our AI helps ensure your periodic safety reports meet current EMA and global standards.

Yes, Assyro AI covers pharmacovigilance regulations from FDA, EMA, PMDA, Health Canada, and other agencies. We track changes to reporting requirements, timelines, and format specifications.

Assyro automates the manual work that limits your capacity: document drafting, eCTD validation, and regulatory intelligence tracking. Consultants using Assyro typically manage 3-5x more client programs at the same quality level.

Yes. Assyro supports per-client workspaces so you can manage multiple programs with full separation. Many consultants offer Assyro-powered regulatory intelligence as a premium value-added service.

Regulatory Context

PV/Drug Safety teams in Consulting depend on current regulatory intelligence to keep submissions, quality narratives, and inspection responses aligned with health-authority expectations.

Global regulatory frameworksFDA/EMA/PMDA guidanceICH guidelines

Common Mistakes

  • Running signal reviews on fixed schedules without event-triggered checks.
  • Weak integration between safety findings and label/risk communication updates.
  • Limited visibility into enforcement trends that predict agency scrutiny.

Key Regulatory Terms

Relevant Regulatory Intelligence

Related Actions

Other Roles in Consulting

PV/Drug Safety in Other Industries

Ready to Transform Your PV/Drug Safety Operations?

See how Assyro AI can accelerate regulatory work for pharmacovigilance professionals in regulatory consulting firms.

Schedule a Demo